VolitionRX (VNRX) Stock Chart & Stock Price History $0.69 +0.01 (+1.16%) As of 03:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock VolitionRX Stock Price Performance The VolitionRX (VNRX) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 6.80%, reflecting recent market activity. As of the latest close, VolitionRX traded at $0.68 with a market cap of $73.28 million and volume of 123,272 shares. Receive VNRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VolitionRX and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.86%1 Month Performance-6.80%3 Month Performance+33.28% VNRX Stock Chart for Friday, August, 22, 2025 VNRX Chart by TradingView VolitionRX Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$0.66$0.68+3.15%$0.69$0.66123,272 shs$73.28 million08/20/2025$0.67$0.66-1.90%$0.70$0.6688,772 shs$71.04 million08/19/2025$0.68$0.67-1.48%$0.71$0.67218,166 shs$69.98 million08/18/2025$0.69$0.68-1.70%$0.72$0.68165,337 shs$71.03 million08/15/2025$0.64$0.69+7.94%$0.76$0.62985,563 shs$72.26 million08/14/2025$0.62$0.64+3.84%$0.67$0.62117,942 shs$66.94 million08/13/2025$0.63$0.62-1.15%$0.64$0.6279,406 shs$64.47 million08/12/2025$0.62$0.63+1.16%$0.65$0.6187,932 shs$65.22 million08/11/2025$0.64$0.62-3.43%$0.65$0.6164,377 shs$64.47 million08/08/2025$0.64$0.64+0.45%$0.65$0.6256,031 shs$66.76 million Get the Latest News and Ratings for VNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VolitionRX and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$0.67$0.64-4.33%$0.68$0.63199,690 shs$66.45 million08/06/2025$0.64$0.67+4.38%$0.68$0.60283,123 shs$69.46 million08/05/2025$0.62$0.64+2.73%$0.65$0.61128,900 shs$66.55 million08/04/2025$0.64$0.62-2.66%$0.65$0.6241,933 shs$64.78 million08/01/2025$0.64$0.64-0.19%$0.66$0.60137,752 shs$66.55 million07/31/2025$0.70$0.64-8.66%$0.72$0.6478,681 shs$66.67 million07/30/2025$0.71$0.70-0.78%$0.73$0.6980,357 shs$72.99 million07/29/2025$0.73$0.71-3.12%$0.74$0.7070,683 shs$73.57 million07/28/2025$0.75$0.73-2.63%$0.80$0.73184,487 shs$75.94 million07/25/2025$0.73$0.75+2.70%$0.75$0.7443,677 shs$77.99 million07/24/2025$0.74$0.73-0.64%$0.76$0.7326,623 shs$75.94 million07/23/2025$0.74$0.74-0.57%$0.77$0.71121,082 shs$76.43 million07/22/2025$0.78$0.74-4.62%$0.78$0.74295,356 shs$76.86 million07/21/2025$0.68$0.78+14.81%$0.79$0.68354,317 shs$80.58 million Related Companies Vor Biopharma Stock Price Chart scPharmaceuticals Stock Price Chart Prima BioMed Stock Price Chart Adherex Technologies Stock Price Chart Neumora Therapeutics Stock Price Chart Tiziana Life Sciences Stock Price Chart Aardvark Therapeutics Stock Price Chart Alumis Stock Price Chart Lineage Cell Therapeutics Stock Price Chart Galectin Therapeutics Stock Price Chart Receive VNRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VolitionRX and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:VNRX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRX Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access